Showing results (51-60 of 696) with videos related to

Sort By:
Pageof 70
Journal of Diabetes and Its Complications|December 21, 2024
Bone mineral density and the risk of kidney disease in patients with type 1 diabetesSabina Chaudhary Hauge, Henrik Øder Hjortkjær, Frederik Persson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2017
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertensionMorten Lindhardt, Frederik Persson, Christina Oxlund, et al.
Plos One|December 28, 2020
Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditionsMie Klessen Eickhoff, Signe Abitz Winther, Tine Willum Hansen, et al.
Kidney International Reports|December 19, 2024
Prognosis for Type 1 Diabetes with Diabetic Nephropathy between 2000 and 2020 - Changes in Kidney Function Decline Over Time and Development of Cardiovascular Disease, Kidney Failure, and MortalityChristina G Poulsen, Kristin Jesse, Bendix Carstensen, et al.
Diabetes Care|July 11, 2023
Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register StudyElisabeth B Stougaard, Hanan Amadid, Esben Søndergaard, et al.
Diabetes|August 9, 2012
Urinary proteomics for early diagnosis in diabetic nephropathyPetra Zürbig, George Jerums, Peter Hovind, et al.
British Journal of Clinical Pharmacology|December 22, 2016
Variability in response to albuminuria-lowering drugs: true or random?Sergei I Petrykiv, Dick de Zeeuw, Frederik Persson, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trialBernt Johan von Scholten, Frederik Persson, Signe Rosenlund, et al.
Diabetes & Metabolism|June 24, 2024
Association of multiple sclerosis with incident diabetes: A nationwide cohort studyJeppe Ravn Jacobsen, Søren L Kristensen, Emil L Fosbøl, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 10, 2011
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trialLian Engelen, Frederik Persson, Isabel Ferreira, et al.
Pageof 70